Trade Mark Journal No.2026/014 3 April 2026

UK00004356316 17 March 2026 (5)

ACRIPTEGA

Class 5: Anti-viral preparations; anti-retroviral agents used in the treatment of acquired immunodeficiency syndrome; Pharmaceuticals for the treatment of infectious diseases caused by the human immunodeficiency virus; Pharmaceuticals; Pharmaceutical preparations.

Mylan Laboratories Limited

Representative: Withers & Rogers LLP